I think that most of the impact of the estrogen controversy is over by now, it has impacted sales, but that should be in the price. It is a little over priced here and there is a worrisome gap to ($18/20) to fill, but I think that that filling may wait till later this summer. I am out right now, but am watching for RSI to drop a little more and see if the $20 area will hold or not.
Market Data 
Markets 
AI
